Sermorelin
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| Trade names | Geref, Gerel |
| Other names | GRF 1–29 |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| Routes of administration |
Injection |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C149H246N44O42S |
| Molar mass | 3357.93 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
|
| |
Sermorelin acetate (INN; brand names Geref, Gerel), also known as GHRH (1-29), is a peptide analogue of growth hormone-releasing hormone (GHRH) which is used as a diagnostic agent to assess growth hormone (GH) secretion for the purpose of diagnosing growth hormone deficiency. It is a 29-amino acid polypeptide representing the 1–29 fragment from endogenous human GHRH, thought to be the shortest fully functional fragment of GHRH.
See also
| GH (somatotropin) |
|
|---|---|
| GHIH (somatostatin) |
|
| GHRH (somatocrinin) |
|
| GHS (ghrelin) |
|
| IGF-1 (somatomedin) |
|